Recent advances in the treatment of colorectal cancer: a review

S Shinji, T Yamada, A Matsuda, H Sonoda… - Journal of Nippon …, 2022 - jstage.jst.go.jp
Departments of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical
School, Tokyo, Japan Colorectal cancer (CRC) is the third most common cancer worldwide …

Epigenetic alterations in colorectal cancer: emerging biomarkers

Y Okugawa, WM Grady, A Goel - Gastroenterology, 2015 - Elsevier
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. One of the
fundamental processes driving the initiation and progression of CRC is the accumulation of …

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus

R Adam, A De Gramont, J Figueras, A Guthrie… - The …, 2012 - academic.oup.com
An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis

PJ Van Dam, EP Van Der Stok, LA Teuwen… - British journal of …, 2017 - nature.com
Background: Liver metastases present with distinct histopathological growth patterns
(HGPs), including the desmoplastic, pushing and replacement HGPs and two rarer HGPs …

Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy

N Halama, S Michel, M Kloor, I Zoernig, A Benner… - Cancer research, 2011 - AACR
Abstract Analysis of tumor-infiltrating lymphocytes (TIL) in primary human colorectal cancer
(CRC) by in situ immunohistochemical staining supports the hypothesis that the adaptive …

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

A Bardelli, S Siena - Journal of clinical oncology, 2010 - ascopubs.org
Personalized cancer medicine based on the genetic milieu of individual colorectal tumors
has long been postulated, but until recently this concept was not supported by clinical …

Surgical management and outcomes of colorectal cancer liver metastases

EJA Morris, D Forman, JD Thomas… - Journal of British …, 2010 - academic.oup.com
Background This population-based study investigated the frequency of hepatic resections
for colorectal cancer metastases across England and their outcome. Methods Individuals …

[HTML][HTML] Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from …

B Nordlinger, E Van Cutsem, T Gruenberger… - Annals of …, 2009 - Elsevier
The past 5 years have seen the clear recognition that the administration of chemotherapy to
patients with initially unresectable colorectal liver metastases can increase the number of …

Circulating DNA as a strong multimarker prognostic tool for metastatic colorectal cancer patient management care

S El Messaoudi, F Mouliere, S Du Manoir… - Clinical Cancer …, 2016 - AACR
Purpose: Circulating cell-free DNA (ccfDNA) is a valuable source of tumor material obtained
from a simple blood sampling that enables noninvasive analysis of the tumor genome. Our …

TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues

G Puppa, A Sonzogni… - Archives of pathology …, 2010 - meridian.allenpress.com
Context.—Colorectal cancer is the leading cause of morbidity and death among
gastrointestinal tumors and ranks fourth after lung, breast, and ovarian cancers. Despite a …